A whole host of studies in different tumour settings (lung, colorectal, cervical, prostate and bladder) postulate a role for thrombomodulin overexpression in reversing epithelial mesenchymal transition (EMT) 43, 44, 45, 46, 47, 48. This evidence concerns the gene THBD and neoplasm.